pentamethylmelamine has been researched along with Cancer of Kidney in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casper, ES; Gordon, C; Gralla, RJ; Jones, BR; Kelsen, DP; Lynch, GR; Woodcock, TM; Young, CW | 1 |
| Abikhalil, F; Atassi, G; Dubois, J; Hanocq, M | 1 |
2 other study(ies) available for pentamethylmelamine and Cancer of Kidney
| Article | Year |
|---|---|
Phase I and pharmacological studies of pentamethylmelamine administered by 24-hour intravenous infusion.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Parenteral; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Nausea; Prognosis; Triazines; Vomiting | 1981 |
Pharmacokinetics and metabolism of hexamethylmelamine in mice bearing renal cell tumors.
Topics: Altretamine; Animals; Biological Availability; Carcinoma, Renal Cell; Kidney Neoplasms; Male; Mathematics; Mice; Triazines | 1988 |